Modifies provisions relating to limits on selling or purchasing certain drugs

HB 1036 sets daily, monthly, and annual purchase limits for over-the-counter drugs containing ephedrine, pseudoephedrine, or phenylpropanolamine - common methamphetamine precursors. It restricts sales to no more than 7.2 grams within 30 days, 3.6 grams within 24 hours, and 61.2 grams annually per person, requiring all such products to be sold behind pharmacy counters. Manufacturers must pay monthly fees starting October 2025 to fund a real-time tracking system, and pharmacies must report sales to authorities. The bill preempts local laws requiring prescriptions for these products and mandates that all sales records be accessible to law enforcement.